John Maraganore

E446842

John Maraganore is a biotechnology executive best known as the founding CEO of Alnylam Pharmaceuticals and a pioneer in the development of RNA interference (RNAi) therapeutics.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (1)

Label Occurrences
John Maraganore canonical 1

Statements (30)

Predicate Object
instanceOf biotechnology executive
businessperson
chief executive officer
associatedWith Alnylam Pharmaceuticals leadership team NERFINISHED
RNAi therapeutics field
employer Alnylam Pharmaceuticals NERFINISHED
field RNA interference therapeutics
biotechnology
pharmaceutical industry
hasExpertise RNA interference
biopharmaceutical company building
drug development
hasReputation leader in biotechnology entrepreneurship
pioneer in RNAi therapeutics
industry biotechnology
pharmaceuticals
knownFor founding CEO of Alnylam Pharmaceuticals
leadership in RNAi drug development
pioneering RNA interference therapeutics
nationality American
notableFor helping translate RNAi biology into approved drugs
notableWork advocacy for RNAi as a new class of medicines
development of RNAi-based medicines
occupation biotechnology executive
corporate director
positionHeld Board member at multiple biotechnology companies
Chief Executive Officer of Alnylam Pharmaceuticals
founding CEO of Alnylam Pharmaceuticals
roleIn commercialization of RNAi therapeutics
strategic direction of Alnylam Pharmaceuticals

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Alnylam Pharmaceuticals foundedBy John Maraganore